Progyny

Yahoo Finance • 6 days ago

Smart ring firm Ōura confidentially files for U.S. IPO (update)

[Wooden blocks with the word IPO and virtual stock graph. Initial Public Offering or stock launch concept.] fadfebrian Smart ring maker Ōura Health Oy, which competes with tech heavyweights such as Apple (AAPL [https://seekingalpha.com/sy... Full story

Yahoo Finance • 8 days ago

StubHub, Jazz Pharmaceuticals upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Guggenheim upgraded StubHub (STUB) to... Full story

Yahoo Finance • 17 days ago

Trump administration proposes easier employer access to IVF benefits

[Writing note showing Benefits. Business photo showcasing hike in allowance for senior employees of the company written on Wood Piece holding by man on the Blue Jeans background.] Artur/iStock via Getty Images The Trump administration sai... Full story

Yahoo Finance • 19 days ago

Progyny anticipates 2026 revenue of $1.365B-$1.405B while raising adjusted EBITDA to $232M-$244M

Earnings Call Insights: Progyny (PGNY) Q1 2026 MANAGEMENT VIEW * “We’re pleased to report that we’ve had a good start to the year with record first quarter revenue coming in at the higher end of our expectations. And net income, earnin... Full story

Yahoo Finance • last month

Progyny Expands Access to Fertility and Women’s Health with Industry’s First Fully Insured Supplemental Plan

NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announces Progyny Select, the industry’s first fully insured, comprehensive supplemental fe... Full story

Yahoo Finance • 2 months ago

2 Reasons to Sell PGNY and 1 Stock to Buy Instead

Although the S&P 500 is down 2.1% over the past six months, Progyny’s stock price has fallen further to $17.17, losing shareholders 16.6% of their capital. This was partly driven by its softer quarterly results and might have investors con... Full story

Yahoo Finance • 2 months ago

Progyny CEO Details Utilization Trends, Forecasting and Progyny Select Fully Insured Rollout at Conference

Progyny logo Key Points Utilization, not eligible lives: Anevski said Progyny focuses on actual benefit use rather than fluctuating eligibility counts, noting utilization has been stable historically around ~1.03%–1.09%. Progyny Select r... Full story

Yahoo Finance • 3 months ago

Barclays Raises Hims & Hers (HIMS) Target to $29 After Novo Deal Clears Legal Overhang — Canaccord Cuts Progyny (PGNY) on Cautious 2026 Outlook

Quick Read Hims & Hers Health (HIMS) reached $2.347 billion in full-year revenue, up 59% year-over-year, with a subscriber base crossing 2.5 million and monthly revenue per subscriber at $83. Progyny (PGNY) posted $1.289 billion in full-y... Full story

Yahoo Finance • 3 months ago

Centene tumbles on ACA warnings but leads managed care with top Buy Quant rating

[medicare word written on wood block and stethoscope on a pink background] Alena Zharava/iStock via Getty Images Centene (CNC [https://seekingalpha.com/symbol/CNC]) shares tumbled about 11% Tuesday after CEO Sarah London warned at the Bar... Full story

Yahoo Finance • 3 months ago

Progyny, Inc. Executives to Participate in Upcoming Investor Conferences

NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that several members of its leadership team will participate in upcoming investor... Full story

Yahoo Finance • 3 months ago

Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2025 Results Report

NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, will report its financial results for the quarterly period and full year ended December 31, 2025,... Full story

Yahoo Finance • 5 months ago

Has Progyny’s 85.7% Surge in 2025 Already Priced In Its Growth Story?

If you are wondering whether Progyny's recent run makes it attractive at today’s price, or if you have already missed the upside, this breakdown will help you understand what the market is really pricing in. Progyny has quietly put up a st... Full story

Yahoo Finance • 6 months ago

Galvanize Therapeutics Appoints Laura Francis to its Board of Directors

REDWOOD CITY, Calif., Nov. 24, 2025 /PRNewswire/ -- Galvanize ("Galvanize") Therapeutics, Inc., a commercial-stage medical technology company pioneering pulsed electric field (PEF) therapies for oncology and chronic lung disease, today ann... Full story

Yahoo Finance • 6 months ago

Merit Medical Systems, Globus Medical, Tenet Healthcare, Progyny, and IQVIA Shares Are Soaring, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a fur... Full story

Yahoo Finance • 6 months ago

Progyny, Inc. to Present at Jefferies Global Healthcare Conference

NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that Mark Livingston, Progyny’s Chief Financial Officer, will participate in a fir... Full story

Yahoo Finance • 7 months ago

Progyny signals $200M share repurchase and targets $1.278B 2025 revenue while expanding supplemental fertility plans

Earnings Call Insights: Progyny, Inc. (PGNY) Q3 2025 MANAGEMENT VIEW * CEO Peter Anevski highlighted a strong quarter, stating "Progyny had a very strong third quarter with revenue and profitability that exceeded the high end of our gu... Full story

Yahoo Finance • 7 months ago

Progyny, Inc. Announces Third Quarter 2025 Results

Reports Revenue of $313.3 Million, Reflecting 9.3% Growth Raises Full Year Guidance to Reflect Continued Strength in Member Engagement Selling Season Yields Over 80 New Clients, 900,000 New Lives, and Near 100% Retention of Existing Base... Full story

Yahoo Finance • 7 months ago

Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and Menopause

NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced the launch of its pregnancy, postpartum, and menopause programs for global employe... Full story

Yahoo Finance • 7 months ago

Progyny seesaws amid confusion over impact from Trump’s IVF initiative

[Down is Up. Up is Down.] Kenneth Cheung/iStock via Getty Images Shares of fertility benefits provider Progyny (NASDAQ:PGNY [https://seekingalpha.com/symbol/PGNY]) turned volatile as the Trump administration announced a new initiative to... Full story

Yahoo Finance • 8 months ago

Progyny CEO Named World Economic Forum Champion for Women’s Health

NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that CEO Pete Anevski has been honored with the recognition as a Champion for Wome... Full story